SCHEMBL12070583

SCHEMBL12070583

COc1cc2cc(-c3cc(-c4ccccc4)cc(-c4ccccc4)c3)nc(Oc3ccccc3)c2cc1OC

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAC1 P63000 2/20 0.49
▸ SMN1; SMN2 Q16637 4/20 0.47
▸ HPGD P15428 3/20 0.47
▸ LMNA P02545 2/20 0.47
▸ KDM4E B2RXH2 7/20 0.46
▸ MEN1 O00255 4/20 0.46
▸ KMT2A Q03164 4/20 0.46
▸ NPC1 O15118 1/20 0.46
▸ RAB9A P51151 1/20 0.46
▸ ALDH1A1 P00352 5/20 0.45
▸ ACACA Q13085 1/20 0.44
▸ HTT P42858 2/20 0.44
▸ TSHR P16473 2/20 0.44
▸ ATM Q13315 2/20 0.44
▸ USP2 O75604 1/20 0.44
▸ MAPK1 P28482 1/20 0.44
▸ HSD17B10 Q99714 1/20 0.44
▸ TRPA1 O75762 1/20 0.43
▸ CYP1A2 P05177 1/20 0.43
▸ CYP3A4 P08684 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16510396 0.91 RAC1 (0.43) RAC1SMN1; SMN2HPGDLMNAKDM4E
SCHEMBL14927008 0.84 LMNA (0.43) SMN1; SMN2HPGDLMNAKDM4EMEN1
SCHEMBL147237 0.81 RAC1 (0.68) RAC1SMN1; SMN2HPGDLMNAKDM4E
SCHEMBL9986895 0.80 SMN1; SMN2 (0.50) RAC1SMN1; SMN2HPGDLMNAKDM4E
SCHEMBL12070505 0.80 RAD52 (0.53) RAC1SMN1; SMN2HPGDLMNAKDM4E
SCHEMBL12072698 0.77 SMN1; SMN2 (0.48) RAC1SMN1; SMN2HPGDLMNAKDM4E
SCHEMBL16510761 0.77 RAC1 (0.35) RAC1SMN1; SMN2HPGDLMNAKDM4E
SCHEMBL12071506 0.76 SMN1; SMN2 (0.47) RAC1SMN1; SMN2HPGDLMNAKDM4E
SCHEMBL28251582 0.75 SMN1; SMN2 (0.51) RAC1SMN1; SMN2HPGDLMNAKDM4E
SCHEMBL147920 0.74 RAC1 (0.71) RAC1SMN1; SMN2HPGDLMNAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8933096-B2 Antimicrobial agents Rugers, The State University of New Jersey (US) 2015-01-13 — — US disclosed
US-20130116278-A1 ANTIMICROBIAL AGENTS RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY 2013-05-09 — — US disclosed
WO-2011159926-A1 ANTIMICROBIAL AGENTS RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 2011-12-22 — — WO disclosed
WO-2011156626-A1 ANTIMICROBIAL AGENTS RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 2011-12-15 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130116278-A1 ANTIMICROBIAL AGENTS MRPL21, ARG1, RPP30 RAC1 356/4885SMN1; SMN2 3496/4885HPGD 4277/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback